GLP-1 Receptor Agonists Show PMOS Potential, Reproductive Safety and Psychiatric Effects Require More Data.
The Neuroendocrine-Appetite-Mental Health Triangle in PMOS: Implications for GLP-1 Receptor Agonist Therapy.
Abstract
GLP-1 Receptor Agonists show therapeutic potential for Polyendocrine Metabolic Ovarian Syndrome (PMOS), addressing metabolic, reproductive, and psychotropic aspects. Reproductive safety and psychiatric effects require further evidence.